FDA issued a Warning Letter to Acorda Therapeutics Inc. on 5/10/2012 as a result of this inspection.
483 Acorda Therapeutics Sep 2011

483 Acorda Therapeutics Sep 2011

Demitria Xiradakis FDA$119.00 - Available Now

FDA investigators audited the Acorda Therapeutics - Ardsley, NY, United States facility and issued 10 inspectional observations (via FDA 483) on 09 Sep 2011.

Product details

  • Category: Human Drugs
  • Number of Observations: 10
  • Inspection end: 09 Sep 2011
  • Location: Ardsley, United States
  • FEI: 3002457563
Add To Cart